Strategies to find, test, and treat people living with hep C in Australia

Australia has committed to eliminating hepatitis C by 2030, with targets to increase diagnoses and treatment, and reduce new infections and liver-related deaths. Hepatitis C therapies with cure rates of over 95% are one of the greatest medical advances in decades, having led to declines in liver-related mortality. Our ability to meet the WHO targets in Australia is threatened by declines in annual hepatitis C RNA testing and treatment.

Ahead of World Hepatitis Day, this special event will include presentations from the Kirby Institute; Hepatitis Australia; Australasian Society for HIV, Viral Hepatitis, and Sexual Health Medicine (ASHM); and Burnet Institute on efforts to help find, test, and treat people living with hepatitis C in Australia. The seminar will include a panel discussion on the key requirements that are needed to facilitate hepatitis C elimination as we approach 2030.

Check out our event page for speaker bios and latest updates: https://kirby.unsw.edu.au/event/strategies-find-test-and-treat-people-living-hepatitis-c-australia

To learn more about World Hepatitis Day: https://www.worldhepatitisday.org.au/